Drugs / WN-80E
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00707642 | May 2008 → Jun 2009 | Flaviviridae infectious disease | Hawaii Biotech, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WN-80E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00707642 ↗ |
| Known as | WN-80E COMPONENT OF HBV-002 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594512 ↗ |
| Modality | Vaccine | “West Nile Recombinant Subunit Vaccine” NCT00707642 ↗ |